Sonendo Inc
OTC:SONX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sonendo Inc
Operating Income
Sonendo Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sonendo Inc
OTC:SONX
|
Operating Income
-$28.8m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
35%
|
CAGR 10-Years
16%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Operating Income
$1.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$5.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$8.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$3B
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
Sonendo Inc
Glance View
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 219 full-time employees. The company went IPO on 2021-10-29. The firm has developed GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company is focused on leveraging the GentleWave System, a root canal therapy for late-stage tooth decay that employs a sterilized, single-use procedure instrument. In addition to its GentleWave console and single-use procedure instruments, it also offers single-use products, such as SoundSeal and the Company's Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown. Its EDTA is a liquid used during the GentleWave Procedure to help debride and disinfect the root canal system. The company also offers TDO practice management software.
See Also
What is Sonendo Inc's Operating Income?
Operating Income
-28.8m
USD
Based on the financial report for Dec 31, 2024, Sonendo Inc's Operating Income amounts to -28.8m USD.
What is Sonendo Inc's Operating Income growth rate?
Operating Income CAGR 5Y
9%
Over the last year, the Operating Income growth was 49%. The average annual Operating Income growth rates for Sonendo Inc have been 13% over the past three years , 9% over the past five years .
